Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a post on X about recent paper he and colleagues co-authored, published in Biometrics.
“New Bayesian Precision Medicine PGen I-II design just published in Biometrics.
It fuses early efficacy/toxicity with long-term outcomes and adaptively clusters subgroups to personalize dosing, beating designs that ignore heterogeneity.”
Title: Precision generalized phase I-II designs
Authors: Saijun Zhao, Peter F Thall, Ying Yuan, Juhee Lee, Pavlos Msaouel, Yong Zang
Read The Full Article Biometrics.
More posts featuring Pavlos Msaouel on OncoDaily.